MIRIMUS

Mirimus, Inc. produces custom genetically engineered mouse models (GEMMs) with reverse gene silencing capabilities by harnessing the power of RNA interference (RNAi). By fusing together proprietary RNAi technology with an efficient mouse engineering strategy, Mirimus holds the leading platform for rapid and cost-effective production of RNAi-GEMMs that serve as invaluable pre-clinical tools to help direct drug discovery research. RNAi-GEMMs are a unique and superior alternative to knockout mice t... hat increase the confidence of drug discovery research prior to entering clinical trials. The ability to transiently suppress a specific gene target within the whole organism makes RNAi-GEMMs an effective tool to be used for target identification and/or validation as well as assessment of target efficacy and toxicity. Transgenic RNAi rodents will undoubtedly become indispensible to the pharmaceutical and biotechnology industry by directing the development of effective and well-tolerated therapeutic strategies to combat the leading ailments of humankind.
MIRIMUS
Industry:
Biotechnology Genetics Life Science
Founded:
2011-01-01
Address:
Cold Spring Harbor, New York, United States
Country:
United States
Website Url:
http://www.mirimus.com
Total Employee:
11+
Status:
Active
Contact:
516) 882-7111
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
XPRIZE
XPRIZE investment in Grant - Mirimus
Official Site Inspections
http://www.mirimus.com Semrush global rank: 7.9 M Semrush visits lastest month: 410
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108

More informations about "Mirimus"
Mirimus
Mirimus is an XPRIZE award-winning biotech and preclinical CRO delivering scalable solutions for the preclinical evaluation of novel therapeutic targets through the use of our advanced โฆSee details»
Mirimus
Mirimus is an award-winning New York biotech company that propels the scientific research behind medical breakthroughs. The company addresses human health issues on a global โฆSee details»
We are a best-in-class innovator addressing health issues on a โฆ
As an essential partner to patients, physicians, researchers, and pharmaceutical companies navigating the complex landscape of diseases, Mirimus is constantly innovating and evolving โฆSee details»
Mirimus - Crunchbase Company Profile & Funding
By fusing together proprietary RNAi technology with an efficient mouse engineering strategy, Mirimus holds the leading platform for rapid and cost โฆSee details»
Mirimus Inc. | BIO-Europe - Informa Connect
Established in 2010 out of Cold Spring Harbor Laboratory with the mission to transform its cutting-edge RNA interference technologies into effective gene silencing therapeutics, Mirimus is a โฆSee details»
Mirimus - LinkedIn
Today, Mirimus markets multiple unique and high-value drug discovery and diagnostic products and services, and is advancing a pipeline of therapeutic candidates in partnership with leading...See details»
Mirimus, Inc - VentureRadar
Mirimus is an XPRIZE award-winning biotech and preclinical CRO specializing in the scalable evaluation of novel therapeutic targets using advanced genetically engineered in vivo models.See details»
Mirimus Diagnostics - Home
As an essential partner to patients, physicians, researchers, and pharmaceutical companies navigating the complex landscape of diseases, Mirimus is constantly innovating and evolving โฆSee details»
Mirimus Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Mirimus.See details»
Mirimus - Our Companies
Mirimus seamlessly integrates three distinct yet synergistic companies: Mirimus Diagnostics, offering cutting-edge clinical laboratory services; Mirimus Preclinical, providing comprehensive โฆSee details»
Mirimus - Overview, News & Similar companies | ZoomInfo.com
Jul 20, 2021ย ยท View Mirimus (www.mirimus.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
NYU Tandon scientists and Brooklyn Biotech, Mirimus, team up for ...
Aug 8, 2022ย ยท Mirimus is a local Brooklyn health biotech company making waves in the medical testing field. The company was established in 2010 by co-founder and CEO Dr. Prem โฆSee details»
Mirimus, Inc. Forms Strategic Collaboration with Biogen to โฆ
Jul 21, 2021ย ยท Mirimus was established in 2010 with the goal of creating a scalable and cost-effective pipeline for model generation and therapeutic development by harnessing the power โฆSee details»
Mirimus
By leveraging our cutting-edge technology and uniquely skilled personnel, Mirimus was able to launch its monkeypox laboratory developed test (LDT) shortly after the World Health โฆSee details»
Mirimus, Inc | VentureRadar
Mirimus is an XPRIZE award-winning biotech and preclinical CRO specializing in the scalable evaluation of novel therapeutic targets using advanced genetically engineered in vivo models. โฆSee details»
Mirimus Named A Winner in $6M XPRIZE Rapid COVID Testing โฆ
NEW YORK, March 16, 2021 /PRNewswire/ -- Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced it has been named as one of five winners in โฆSee details»
Mirimus, Inc. Announces Publication of Scientific Paper โฆ
Feb 22, 2021ย ยท SalivaClear, developed by Mirimus, Inc., is a pioneering COVID-19 testing platform that combines saliva-based sampling, pooled testing and PCR diagnostics to enable high โฆSee details»
Careers - Mirimus
Weโre a team of mission-driven professionals working together to revolutionize drug discovery, diagnostics and therapeutics for the world's most pressing health issues.See details»
Mirimus, Inc. Announces Publication of Research in The Lancet ...
Jul 19, 2021ย ยท SalivaClear, developed by Mirimus, Inc., is a pioneering COVID-19 testing platform that combines saliva-based sampling, pooled testing and PCR diagnostics to enable high โฆSee details»
Mirimus Reviews: What Is It Like to Work At Mirimus?
Mirimus has an overall rating of 3.3 out of 5, based on over 25 reviews left anonymously by employees. 53% of employees would recommend working at Mirimus to a friend and 80% โฆSee details»